Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19.

Wang, Leonard K; Kuo, Yong-Fang; Westra, Jordan; Raji, Mukaila A; Albayyaa, Mohanad; Allencherril, Joseph; Baillargeon, Jacques

Wang, Leonard K; Kuo, Yong-Fang; Westra, Jordan; Raji, Mukaila A; Albayyaa, Mohanad; Allencherril, Joseph; Baillargeon, Jacques.

Afiliação

Wang LK; John Sealy School of Medicine, University of Texas Medical Branch, Galveston.
Kuo YF; Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston.
Westra J; Department of Internal Medicine, University of Texas Medical Branch, Galveston.
Raji MA; Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston.
Albayyaa M; Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston.
Allencherril J; Department of Internal Medicine, University of Texas Medical Branch, Galveston.
Baillargeon J; Institute for Translational Sciences, University of Texas Medical Branch.

Am J Med Open ; 9: 100040, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37207280

Palavras-chave

Anticoagulants; COVID-19; Renin-angiotensin-aldosterone system blockers; Statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Med Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google